Artwork for podcast Pathfinders in Biopharma
A call to action: Global Blood Therapeutics on tackling orphan disease
Episode 108th December 2021 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:27:32

Share Episode


What does it take to tackle the most perplexing orphan diseases? Ted W. Love, M.D., President and CEO, Global Blood Therapeutics (GBT), speaks with RBC Capital Markets’ Senior Biotechnology Analyst Gregory Renza, M.D., about having a mission and the drive to succeed on this episode of Pathfinders.